Novo Nordisk AS (NVO)
101.74
-3.58
(-3.40%)
USD |
NYSE |
Nov 15, 16:00
102.00
+0.26
(+0.26%)
After-Hours: 20:00
Novo Nordisk Shares Outstanding: 4.444B for Nov. 8, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 08, 2024 | 4.444B |
November 04, 2024 | 4.450B |
October 25, 2024 | 4.450B |
October 11, 2024 | 4.451B |
October 04, 2024 | 4.451B |
September 27, 2024 | 4.451B |
September 20, 2024 | 4.451B |
September 13, 2024 | 4.451B |
September 06, 2024 | 4.452B |
August 30, 2024 | 4.452B |
August 23, 2024 | 4.452B |
August 16, 2024 | 4.452B |
August 09, 2024 | 4.452B |
August 05, 2024 | 4.453B |
July 26, 2024 | 4.453B |
July 19, 2024 | 4.453B |
July 12, 2024 | 4.453B |
July 05, 2024 | 4.453B |
June 28, 2024 | 4.454B |
June 21, 2024 | 4.454B |
June 14, 2024 | 4.454B |
June 07, 2024 | 4.454B |
May 31, 2024 | 4.454B |
May 24, 2024 | 4.454B |
May 16, 2024 | 4.455B |
Date | Value |
---|---|
May 06, 2024 | 4.455B |
April 30, 2024 | 4.461B |
April 26, 2024 | 4.461B |
April 24, 2024 | 4.461B |
April 19, 2024 | 4.461B |
April 12, 2024 | 4.462B |
April 05, 2024 | 4.462B |
March 27, 2024 | 4.462B |
March 22, 2024 | 4.462B |
March 15, 2024 | 4.462B |
March 08, 2024 | 4.462B |
March 01, 2024 | 4.463B |
February 16, 2024 | 4.463B |
February 09, 2024 | 4.463B |
January 30, 2024 | 4.456B |
January 29, 2024 | 4.456B |
January 19, 2024 | 4.457B |
January 12, 2024 | 4.457B |
January 05, 2024 | 4.458B |
December 31, 2023 | 4.458B |
December 21, 2023 | 4.458B |
December 15, 2023 | 4.459B |
December 08, 2023 | 4.459B |
December 01, 2023 | 4.460B |
November 24, 2023 | 4.460B |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
4.444B
Minimum
Nov 08 2024
4.80B
Maximum
Dec 31 2019
4.552B
Average
4.535B
Median
May 12 2022
Shares Outstanding Benchmarks
Ascendis Pharma AS | 59.76M |
Amgen Inc | 537.53M |
AstraZeneca PLC | 3.101B |
Grifols SA | 679.63M |
Viking Therapeutics Inc | 111.44M |